BioSpace News Archive

Researchers at the Washington University School of Medicine in St. Louis, Mo., led by neurosurgeon Dr. Albert H. Kim, found direct evidence in mice that the focal thermal effect of laser interstitial thermal therapy opens the blood-brain barrier and blood-tumor barrier.

Growing bench of proven leaders in clinical lung intelligence and health technology bolsters both product and commercial advances

The NIAID funded grant will help advance AUM LifeTech’s preclinical program on HIV therapy using self-delivering RNA silencing technology

Immuneering Corporation announced the company’s participation in Oppenheimer’s Private Life Sciences Company Call Series taking place virtually August 17-19, 2020.

Chemotherapy usually cures children diagnosed with acute lymphoblastic leukemia, but the treatment may hamper brain development and impact key cognitive functions including sensory processing, memory, and attention.

American Gene Technologies (AGT) announced today approval by the FDA (Food and Drug Administration) to begin Phase 1, the first human clinical trial for AGT’s lead HIV program . AGT will conduct its Phase 1 study at clinical sites in the Baltimore/D.C. area, and has named Washington Health Institute, University of Maryland, Institute of Human Virology and Georgetown University as its initial trial sites. These sites are expected to

Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2021 on Tuesday, August 25, 2020. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at http://newsroom.medtronic.com . The news release will include summary financial information for the company’s first quarter of fiscal year 2021, which ended on Friday, July 31, 2020. Medtroni

Summer is Lyme disease season. It’s a disease that afflicts as many as 400,000 Americans every year and can lead to a number of serious, life-threatening problems if not caught early.

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today formation of Campbell Neurosciences, a new division of the Company dedicated to approaching suicide as a biological disorder and developing science-based diagnostic tools and interventions.

Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19.